BPMC

Blueprint Medicines
BPMC

Overview Fund Activity
Delisted

BPMC was delisted on the 17th of July, 2025.

Back to rankings

70 hedge funds and large institutions have $509M invested in Blueprint Medicines in 2015 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 29 increasing their positions, 21 reducing their positions, and 10 closing their positions.

Holders
70
Holders Change
–
Holders Change %
0%
% of All Funds
1.96%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
11
Increased
29
Reduced
21
Closed
10
Calls
$102K
Puts
$70K
Net Calls
+$32K
Net Calls Change
+$32K

Top Buyers

1
Deutsche Bank
1
Deutsche Bank
Germany
$3.92M
2
PHS
2
PFM Health Sciences
California
$21M
3
RIM
3
RS Investment Management
California
$13.5M
4
OM
4
Opaleye Management
Massachusetts
$2.77M
5
Wellington Management Group
5
Wellington Management Group
Massachusetts
$27M

Top Sellers

1
JPMorgan Chase & Co
1
JPMorgan Chase & Co
New York
$1.95M
2
Citadel Advisors
2
Citadel Advisors
Florida
$11.7M
3
Ameriprise
3
Ameriprise
Minnesota
$1.88M
4
Lord, Abbett & Co
4
Lord, Abbett & Co
New Jersey
$13.7M
5
ACPU
5
Arrowgrass Capital Partners (US)
Delaware
$0
Name Market Value Shares Shares
Change 		Shares
Change %
BG
76
BlackRock Group
United Kingdom
– – -6,724 Closed
GGHC
77
Gilder Gagnon Howe & Co
New York
– – -4,710 Closed
SO
78
STRS Ohio
Ohio
– – -3,000 Closed
US Bancorp
79
US Bancorp
Minnesota
– – -1,096 Closed
Invesco
80
Invesco
Georgia
– – -177 Closed
1 2 3
4